MetLife Investment Management’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $134K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $74.8K | Sell |
|
|||||
|
2024
Q2 | $175K | Buy |
|
|||||
|
2024
Q1 | $273K | Hold |
|
|||||
|
2023
Q4 | $408K | Hold |
|
|||||
|
2023
Q3 | $364K | Hold |
|
|||||
|
2023
Q2 | $481K | Hold |
|
|||||
|
2023
Q1 | $685K | Hold |
|
|||||
|
2022
Q4 | $750K | Hold |
|
|||||
|
2022
Q3 | $883K | Hold |
|
|||||
|
2022
Q2 | $830K | Hold |
|
|||||
|
2022
Q1 | $1.37M | Buy |
|
|||||
|
2021
Q4 | $981K | Hold |
|
|||||
|
2021
Q3 | $1.41M | Hold |
|
|||||
|
2021
Q2 | $2.01M | Sell |
|
|||||
|
2021
Q1 | $1.78M | Sell |
|
|||||
|
2020
Q4 | $2.33M | Sell |
|
|||||
|
2020
Q3 | $1.96M | Sell |
|
|||||
|
2020
Q2 | $1.77M | Buy |
|
|||||
|
2020
Q1 | $1.3M | Hold |
|
|||||
|
2019
Q4 | $1.53M | Hold |
|
|||||
|
2019
Q3 | $1.12M | Hold |
|
|||||
|
2019
Q2 | $845K | Hold |
|
|||||
|
2019
Q1 | $815K | Hold |
|
|||||
|
2018
Q4 | $507K | Hold |
|
|||||
|
2018
Q3 | $743K | Hold |
|
|||||
|
2018
Q2 | $1.04M | Hold |
|
|||||
|
2018
Q1 | $1.13M | Hold |
|
|||||
|
2017
Q4 | $900K | Buy |
|